Table 1.
Baseline characteristics of the patients
| Parameters | COVID-19 positive patients (n = 30) |
COVID-19 negative patients (n = 30) |
p value |
|---|---|---|---|
| Age (yrs) ± SD | 63 ± 8.3 | 61.3 ± 9.5 | NS |
| Gender | Male | Male | Not applicable |
| Body mass index (BMI) kg/m2 | 21.43 ± 1.62 | 21.35 ± 1.64 | NS |
| Comorbidities |
None − 11 (36%) Hypertension 8 (26%) Diabetes 9 (30%) Osteoarthritis 2 (6%) |
None − 16 (53%) Hypertension 7 (23%) Diabetes 7 (23%) |
- |
| Total leucocyte count (TLC) 1 × 103/µL, median (IQR) | 10,765 (5780) | 14,312 (3700) | p < 0.005 |
| Haemoglobin (Hb) (g/dl), median (IQR) | 12.07 (2.5) | 9.85 (1.12) | p < 0.005 |
| Absolute neutrophil count (ANC), median (IQR) | 7280 (4130) | 4320 (3125) | p < 0.005 |
| Absolute leukocyte count (ALC), median (IQR) | 1070 (630) | 990 (540) | p < 0.005 |
| Neutrophil/lymphocyte (N/L) ratio, median (IQR) | 7.1 (6.2) | 6.8 (4.3) | p < 0.005 |
| Platelet count 1 × 103/µL) median (IQR) | 159.5(128) | 210 (94) | p < 0.005 |
| INR, median (IQR) | 1.11 (0.27) | 0.87 (0.12) | p < 0.005 |
Mann-Whitney U test is used to test the significance; p < 0.05 (significant); NS- not significant